Recently, the field of diabetes treatment has witnessed a surge in innovation with the development of novel therapies targeting get more info GLP-1 receptors. Among these groundbreaking advancements are retatrutide and trizepatide, two highly promising medications that exhibit impressive therapeutic effects over traditional therapies. Retatrutide,